aprepitant and Cerebellar-Diseases

aprepitant has been researched along with Cerebellar-Diseases* in 1 studies

Other Studies

1 other study(ies) available for aprepitant and Cerebellar-Diseases

Article	Year
Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old question. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2009, Volume: 11, Issue:7 Topics: Antiemetics; Aprepitant; Cerebellar Diseases; Cerebellar Neoplasms; Glioblastoma; Humans; Morpholines; United States; United States Food and Drug Administration	2009

Article

Year

Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old question.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2009, Volume: 11, Issue:7

Topics: Antiemetics; Aprepitant; Cerebellar Diseases; Cerebellar Neoplasms; Glioblastoma; Humans; Morpholines; United States; United States Food and Drug Administration

2009